Article
SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis
16 Dec 2019
Abstract excerpt
Significance The mitochondrial enzyme glutaminase (GLS) is frequently up-regulated in cancer cells, and a GLS-selective inhibitor is being evaluated in clinical trials. Previous screens identified succinylated lysine residues on GLS, but the functional consequences of these posttranslational modifications have remained unclear. Here, we report that the mitochondrial desuccinylase SIRT5 stabilizes GLS. Both GLS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
